CoChat

Ketamine-facilitated behavioral treatment for cannabis use disorder: A proof of concept study

Azhari, Nour, Hu, Helen, O’Malley, Kate Y., Blocker, Megan E., Levin, Frances R., Dakwar, Elias · 2021 · The American Journal of Drug and Alcohol Abuse

The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Sub-anesthetic ketamine infusions may benefit a range of psychiatric conditions, including alcohol and cocaine use disorders. Currently, there are no effective pharmacological treatments for cannabis use disorder. OBJECTIVES: The objective of this uncontrolled proof of concept trial was to test the feasibility, tolerability, and potential therapeutic effects of integrating ketamine infusions with a behavioral platform of motivational enhancement therapy and mindfulness-based relapse prevention in treating cannabis use disorder (CUD). METHODS: Eight cannabis-dependent individuals (four female, four male) receiving motivational enhancement therapy and mindfulness-based relapse prevention behavioral treatments completed this single-blind outpatient 6-week study. Participants received either one or two infusions of ketamine (0.71 mg/kg [infusion 1]; 1.41 mg/kg [infusion 2] for non-responders) during the study. Participants self-reported cannabis use (Timeline Follow-Back) and underwent an assessment of confidence in abstaining from using cannabis (Drug-Taking Confidence Questionnaire) at predetermined time points throughout the study. RESULTS: Ketamine infusions were well-tolerated and there were no adverse events. Frequency of cannabis use decreased significantly from baseline (B = 5.1, s.e = 0.7) to the week following the first infusion (B = 0.8, s.e = 0.412), and remained reduced at the end of the study (B = 0.5, s.e = 0.3). Participants' confidence in their ability to abstain from cannabis in potentially triggering situations increased significantly from baseline to the end of study. CONCLUSIONS: These findings suggest that combining ketamine with behavioral therapy is feasible,tolerable, and potentially helpful, in treating cannabis-dependent individuals.

Overview

Integrity signals

Registry

Crossref · 10.1080/00952990.2020.1808982

Cites

26 of 26 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 26 references

Research works printed but not linked: 4

  1. Substance Abuse and Mental Health Services Administration, 2019, Key substance use and mental health indicators in the United States: results from the 2018 national survey on drug use and health (HHS Publication No. PEP19-5068, NSDUH series H-54)
  2. 10.1037/0022-006X.74.2.307 · DOI · Paper page
  3. Carlson EB, 1993, Dissociation, 6, 16
  4. Smedslund G, 2011, Cochrane Database Syst Rev, 5, CD008063

Cited by

See all 48

Metadata

Authors
Azhari, N., Hu, H., O’Malley, K. Y., Blocker, M. E., Levin, F. R., & Dakwar, E.
Affiliations
New York State Psychiatric Institute (US)
Corresponding author
Dakwar, Elias
Venue
The American Journal of Drug and Alcohol Abuse
Published
2020-11-11
Volume
47
Issue
1
Pages
92-97
ISSN
  • 0095-2990 (ISSN-L)
  • 1097-9891
OpenAlex
W3098995086
Cited by
48
References
26
Citations by year
2026: 8 · 2025: 15 · 2024: 8 · 2023: 7 · 2022: 8 · 2021: 2
FWCI
3.04
Type
journal article
Language
en
Open access
closed
Locations
  • The American Journal of Drug and Alcohol Abuse (publishedVersion)
  • PubMed (publishedVersion)
  • Swinburne figshare (Swinburne University of Technology) (submittedVersion)
Funders
National Institute of Drug Abuse (DA029647)
Topics
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
  • Health Sciences › Medicine › Pharmacology (medical) › Cannabis and Cannabinoid Research
Keywords
ketamine, cannabis use disorder, motivational enhancement therapy, mindfulness-based relapse prevention, cannabis use reduction
MeSH terms
Proof of Concept Study, Adult, Behavior Therapy, Marijuana Abuse, Female, Humans, Ketamine, Male, Middle Aged, Single-Blind Method, Treatment Outcome, Excitatory Amino Acid Antagonists, Young Adult, Mindfulness

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Ketamine-facilitated behavioral treatment for cannabis use disorder: A proof of concept study. https://app.cochat.ai/papers/10.1080/00952990.2020.1808982
The paper
Azhari, N., Hu, H., O’Malley, K. Y., Blocker, M. E., Levin, F. R., & Dakwar, E. (2021). Ketamine-facilitated behavioral treatment for cannabis use disorder: A proof of concept study. The American Journal of Drug and Alcohol Abuse. https://doi.org/10.1080/00952990.2020.1808982

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.